Can you provide the average price target for HUMANA INC stock?
33 analysts have analysed HUM and the average price target is 222.21 USD. This implies a price increase of 6.89% is expected in the next year compared to the current price of 207.89.
NYSE:HUM • US4448591028
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HUMANA INC (HUM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-13 | Truist Securities | Maintains | Hold -> Hold |
| 2026-04-08 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-04-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-25 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-18 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-17 | Truist Securities | Maintains | Hold -> Hold |
| 2026-02-17 | Goldman Sachs | Maintains | Sell -> Sell |
| 2026-02-13 | TD Cowen | Maintains | Hold -> Hold |
| 2026-02-12 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-02-12 | Guggenheim | Maintains | Buy -> Buy |
| 2026-02-12 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-12 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2026-02-12 | Jefferies | Maintains | Buy -> Buy |
| 2026-02-02 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2026-01-07 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-01-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-18 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-05 | Jefferies | Upgrade | Hold -> Buy |
| 2025-11-25 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-10 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-10 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-10-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 106.374B 14.54% | 117.761B 10.70% | 129.664B 10.11% | 163.565B 26.15% | 173.493B 6.07% | 185.323B 6.82% | 201.039B 8.48% | 215.153B 7.02% | 242.822B 12.86% | 261.588B 7.73% | 281.583B 7.64% | |
| EBITDA YoY % growth | 5.584B 11.72% | 4.011B -28.17% | 4.23B 5.46% | 2.827B -33.17% | 3.723B 31.69% | 5.198B 39.62% | 5.361B 3.14% | 6.468B 20.65% | 7.43B 14.87% | 8.047B 8.30% | 8.721B 8.38% | |
| EBIT YoY % growth | 4.667B 12.38% | 3.043B -34.80% | 3.406B 11.93% | 2.175B -36.14% | 3.044B 39.95% | 4.677B 53.65% | 6.203B 32.63% | 5.956B -3.98% | 6.19B 3.93% | 6.75B 9.05% | 7.364B 9.10% | |
| Operating Margin | 4.39% | 2.58% | 2.63% | 1.33% | 1.75% | 2.52% | 3.09% | 2.77% | 2.55% | 2.58% | 2.62% | |
| EPS YoY % growth | 25.99 3.09% | 16.19 -37.71% | 17.13 5.81% | 9.33 -45.51% | 15.17 62.53% | 25.75 69.70% | 37.50 45.65% | 34.42 -8.23% | 35.73 3.83% | 39.60 10.83% | 43.49 9.82% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 10.13 -12.53% | 4.45 -28.96% | 0.51 -84.21% | -5.91 -49.19% | 11.65 15.06% | 6.20 39.30% | 1.99 288.01% | -4.75 19.56% | 15.00 28.72% | 9.19 48.14% | 3.79 90.76% | -4.14 12.79% |
| Revenue Q2Q % growth | 39.755B 23.80% | 40.924B 26.36% | 41.314B 26.54% | 41.724B 13.88% | 42.489B 6.88% | 42.984B 5.03% | 43.012B 4.11% | 43.147B 3.41% | 45.543B 7.19% | 46.138B 7.34% | 46.209B 7.43% | 46.346B 7.41% |
| EBITDA Q2Q % growth | 1.996B -11.41% | 1.074B -32.24% | 429.66M -66.87% | -692.853M -289.30% | 2.249B 12.68% | 1.309B 21.88% | 662.75M 54.25% | -375.979M 45.73% | 2.855B 26.95% | 1.787B 36.52% | 869.87M 31.25% | -356.772M 5.11% |
| EBIT Q2Q % growth | 1.858B -8.83% | 937.93M -19.07% | 243.58M -63.48% | -910.087M -98.71% | 2.055B 10.60% | 1.164B 24.10% | 445.51M 82.90% | -664.036M 27.04% | 2.591B 26.08% | 1.653B 42.01% | 785.87M 76.40% | -484.881M 26.98% |
All data in USD
33 analysts have analysed HUM and the average price target is 222.21 USD. This implies a price increase of 6.89% is expected in the next year compared to the current price of 207.89.
HUMANA INC (HUM) will report earnings on 2026-04-29, before the market open.
The consensus EPS estimate for the next earnings of HUMANA INC (HUM) is 10.13 USD and the consensus revenue estimate is 39.76B USD.
The expected long term growth rate for HUMANA INC (HUM) is 12.39%.